21 CFR 558.78 : Food And Drugs (§ 1.1 To Parts 1403-1499) — (Subpart A To Parts 590-599) — Food And Drug Administration, Department Of Health And Human Services (Continued) (Subpart A To Parts 590-599) — Animal Drugs, Feeds, And Related Products (Subpart A To Parts 590-599) — New Animal Drugs For Use In Animal Feeds (§ 558.3 To § 558.680) — Specific New Animal Drugs For Use In Animal Feeds (§ 558.55 To § 558.680) — Bacitracin zinc.

4 Aug 2016

(a) Specifications. Type A medicated articles containing bacitracin zinc equivalent to 10, 25, 40, or 50 grams per pound bacitracin.

(b) Approvals. See No. 054771 in § 510.600(c) of this chapter.

(c) Related tolerances. See § 556.70 of this chapter.

(d) Conditions of use. (1) It is used as follows:

Bacitracin zinc in grams per ton Combinations in grams per ton Indications for use Limitations Sponsor
(i) 4 to 50 Chickens: for increased rate of weight gain and improved feed efficiency Growing chickens 054771
(ii) 4 to 50 Turkeys and pheasants: for increased rate of weight gain and improved feed efficiency Growing turkeys and pheasants 054771
(iii) 5 to 20 Quail; for increased rate of weight gain and improved feed efficiency Growing quail; feed as the Type C feed to starting quail through 5 weeks of age 054771
(iv) 10 to 25 Laying chickens; improved feed efficiency and increased egg production 054771
(v) 10 to 50 Swine; increased rate of weight gain and improved feed efficiency Growing and finishing swine 054771
(vi) 20 Growing-finishing swine; increased rate of weight gain In Type C feed 054771
(vii) 20 to 40 Growing-finishing swine; improved feed efficiency ......do 054771

(2) It is used in feed for growing cattle at 35 to 70 milligrams per head per day as follows:

(i) To aid in stimulating growth and improving feed efficiency.

(ii) For increased rate of weight gain and improved feed efficiency; see sponsor 054771.

(3) Bacitracin zinc may also be used in combination with:

(i) Amprolium and ethopabate as in § 558.58.

(ii) Clopidol as in § 558.175.

(iii) Decoquinate as in § 558.195.

(iv) Lasalocid as in § 558.311.

(v) Monensin as in § 558.355.

(vi) Naracin as in § 558.363.

(vii) [Reserved]

(viii) Robenidine as in § 558.515.

(ix) Salinomycin as in § 558.550.


Editorial Note:

For Federal Register citations affecting § 558.78, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at www.fdsys.gov.

21 CFR 558.78
[41 FR 10994, Mar. 15, 1976]